3 Stocks Defying the Dow’s Drop: Bank of America Corp (BAC), Pfizer Inc. (PFE) and More
Despite the lack of critical economic news today, stock markets are falling to start the week. The Dow Jones Industrial Average is down 0.15% as of 3:15 p.m.
Posts Tagged ‘NYSE:PFE’
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks.
Dow Starts Recovering From Early-Morning Drop: Bank of America Corp (BAC), The Home Depot, Inc. (HD)
The Dow Jones Industrial Average opened flat this morning before a sharp fall, bringing it down 40 points in the first few hours of trading.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): 2 Dow Stocks We All Need but Shouldn’t Own
Here at The Motley Fool, we believe the best way to invest and maximize returns is by buying strong companies and owning them for a long time.
Has Elan Corporation, plc (ADR) (ELN) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Why Depomed Inc (DEPO) Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty pharmaceutical company Depomed...
Dow Closes on Positive Note, But Still Down for the Week: Pfizer Inc. (PFE), The Coca-Cola Company (KO)
The Dow Jones Industrial Average ended the day up 48 points, or 0.35%, and now sits at 13,992.
Last Week’s Dow Losers: International Business Machines Corp. (IBM), Exxon Mobil Corporation (XOM)
Another wild week on Wall Street leaves investors basically were they were five days ago.
A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)
Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and Mylan Inc.
Peregrine Pharmaceuticals (PPHM): 50% Upside on this Biotechnology Stock
The patent cliff has positively impacted the valuations of small biopharmaceutical companies due to their acquisition potential.
How Far Can This Blockbuster Take Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Eli Lilly & Co. (LLY): If You’re Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
Investors Pull Back After Yesterday’s Rally: American Express Company (AXP), Caterpillar Inc. (CAT)
The Dow Jones Industrial Average is back in the red today, down 55 points, or 0.39%, as of 2:15 p.m. EST.
The Investor’s Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis...
The Impending Spinoff of a Spinoff: Covidien plc (COV), Pfizer Inc. (PFE), Abbott Laboratories (ABT)
Are you ready for another health-care spinoff? Investors experienced two already in 2013 -- and we're barely into the second month of the year.
Finding Alpha in the Healthcare Space: UnitedHealth Group Inc. (UNH), Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
I'm a big fan of healthcare stocks. Everyone spends money on healthcare at some point in his or her life. Sometimes circumstances are unfortunate, but there is good money ...
5 Big Winners and Losers From Earnings Season: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
Earnings season is a wrap for many of the brightest stars of the health care sector: Big pharma's big disappointments and successes are in the books, and investors are looking...
Teva Pharmaceutical Industries Ltd (TEVA) Earnings: An Early Look
Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors.
Building A Better Drug Portfolio: Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), Amgen, Inc. (AMGN)
When building a drug portfolio, most investors stick to pharmaceutical firms. Since these are generally the largest, most profitable options, it's easy to see why.
Gilead Sciences, Inc. (GILD) Earnings Blaze a Star-Studded Future
The global HIV market supports a large and lucrative business environment.
3 Horrendous Health-Care Stocks This Week: Herbalife Ltd. (HLF), Celsion Corporation (CLSN) and More
It's hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care stocks crashing.
Sex Sells: A Guide For the Socially Responsible Investor, Johnson & Johnson (JNJ), Pfizer Inc. (PFE)
Sex sells. You read this far, didn't you? Socially responsible investors are missing out on some very good companies if they maintain a prudish bent.
3 Ways to Make Money With Zoetis (Even If You Missed the IPO): Pfizer Inc. (PFE)
It's too late. If you wanted to buy into what has been hyped as the biggest IPO since Facebook Inc (NASDAQ:FB), but didn't, you missed your chance. Pfizer Inc.
How the Dogs of the Dow Did in January: Hewlett-Packard Company (HPQ), Verizon Communications Inc. (VZ) and More
Investors have never been hungrier for income, and that hunger has led to renewed interest in investing strategies that focus on maximizing income.
Two Peas in a Pharma Pod: Pfizer Inc (PFE), Bristol Myers Squibb Co. (BMY)
Pfizer's 2012 revenue was down 10%; Bristol-Myers Squibb's was off by 17%. Both are down because of expirations of megablockbusters they used to own.
